Home Cart Sign in  
Chemical Structure| 1303587-99-6 Chemical Structure| 1303587-99-6

Structure of 1303587-99-6

Chemical Structure| 1303587-99-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 1303587-99-6 ]

CAS No. :1303587-99-6
Formula : C6H6ClN3O
M.W : 171.58
SMILES Code : ClC1=NC=C2OCCNC2=N1
MDL No. :MFCD20688597
InChI Key :GYQORXHFUXETMQ-UHFFFAOYSA-N
Pubchem ID :73554181

Safety of [ 1303587-99-6 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Application In Synthesis of [ 1303587-99-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 1303587-99-6 ]

[ 1303587-99-6 ] Synthesis Path-Downstream   1~55

  • 1
  • [ 1303587-99-6 ]
  • [ 1423-26-3 ]
  • [ 1303588-00-2 ]
YieldReaction ConditionsOperation in experiment
52% With sodium carbonate;tetrakis(triphenylphosphine) palladium(0); In 1,4-dioxane; water; at 120℃; for 12h;Inert atmosphere; sealed tube; 2-Chloro-7,8-dihydro-6H-pyrimido[5,4-b][l,4]oxazine (68; 1.41 g, 8.22 mmol), 3- (trifluoromethyl)phenylboronic acid (1.87 g, 9.86 mmol), Pd(PPh3)4 (475 mg, 0.411 mmol), Na2C03 (2.09 g, 19.7 mmol) and dioxane/water(4:l, 35 ml) were added to a sealed tube and filled with nitrogen. Then the mixture was heated to 120 C for 12 hours. After cooling, CH2CI2 (100 mL) was added and the mixture was passed through a pad of Na2SO
  • 2
  • [ 943995-31-1 ]
  • [ 106-93-4 ]
  • [ 1303587-99-6 ]
YieldReaction ConditionsOperation in experiment
72% With potassium carbonate; In dichloromethane; for 4h;Reflux; 4-Amino-2-chloropyrimidin-5-ol (67; 3.75 g, 25.8 mmol) was taken up in CH2CI2 (2500 mL) along with 1,2-dibromoethane (4.85 g, 25.8 mmol) and 2C03 (10.68 g, 77.4 mmol). The resulting reaction mixture was refluxed for 4 h. The solid in the mixture was removed by filtration. The filtrate was concentrated, and the residue was purified by column chromatography to obtain 2-chloro-7,8-dihydro-6H-pyrimido[5,4-b][l ,4]oxazine (68; 3.18 g, 72% yield). MS (ESI) calcd for C6H6C1N30: 171.58; found 173 [M+H].
  • 3
  • [ 1303587-99-6 ]
  • [ 1303585-77-4 ]
  • 4
  • [ 1303587-99-6 ]
  • [ 100-39-0 ]
  • 8-benzyl-2-chloro-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazine [ No CAS ]
YieldReaction ConditionsOperation in experiment
98% To a stirred solution of 2-chloro-7, 8-dihydro-6H-pyrimido [5, 4-b] [1, 4] oxazine (50 mg, 0.29 mmol) in DMF (0.25 mL) under argon atmosphere were added sodium hydride (35 mg, 0.87 mmol) at 0 C. After stirring for 5 mins, benzyl bromide (0.035 mL, 0.29 mmol) was added to the reaction mixture at RT and stirred for 2 h. After consumption of the starting material (monitored by TLC), the reaction was diluted with water (10 mL) and extracted with 5% MeOH/ CH2C12 (2 x 5 mL). The combined organic extracts were dried over sodium sulfate, filtered and concentrated in vacuo. The crude material was purified by column chromatography using 2% MeOH: CH2C12 to afford 8-benzyl-2-chloro-7, 8-dihydro-6H- pyrimido [5, 4-b] [1, 4] oxazine (75 mg, 98%) as an off-white solid. ?H-NMR (DMSO-d6, 400 MHz): oe 7.70 (s, 1H), 7.33-7.21 (m, 5H), 4.78 (s, 2H), 4.20-4.17 (m, 2H), 3.50-3.48 (m, 2H); LCMS: 262.3 (M+1); (column; X-Select CSH C-18 (50 x 3.0 mm, 3.5 jim); RT 4.10 mm. 0.05% Aq TFA: ACN; 0.80 mL/min); TLC: 5% MeOH/ CH2C12 (Rf 0.7).
98% With sodium hydride; In N,N-dimethyl-formamide; mineral oil; at 0 - 20℃; for 2h;Inert atmosphere; Synthesis of 8-benzyl-2-chloro-7, 8-dihydro-6H-pyrimido [5, 4-b] [I, 4] oxazine [0420] To a stirred solution of 2-chloro-7, 8-dihydro-6H-pyrimido [5, 4-b] [1, 4] oxazine 1 (50 mg, 0.29 mmol) in DMF (0.25 mL) under argon atmosphere was added sodium hydride (35 mg, 0.87 mmol) at 0 C. After stirring for 5 mins, benzyl bromide (0.035 mL, 0.29 mmol) was added to the reaction mixture at RT and stirred for 2 h. After consumption of the starting materials (monitored by TLC), the reaction was diluted with water (10 mL) and extracted with 5% MeOH/ CH2CI2 (2 x 5 mL). The combined organic extracts were dried over sodium sulfate, filtered and concentrated in vacuo. The crude material was purified by column chromatography using 2% MeOH: CH2CI2 to afford 8-benzyl-2-chloro-7, 8-dihydro- 6H-pyrimido [5, 4-b] [1, 4] oxazine (75 mg, 98%) as an off-white solid. 1H-NMR (DMSO-<, 400 MHz): delta 7.70 (s, 1H), 7.33-7.21 (m, 5H), 4.78 (s, 2H), 4.20-4.17 (m, 2H), 3.50-3.48 (m, 2H); LCMS: 262.3 (M+l); (column; X-Select CSH C-18 (50 3.0 mm, 3.5 mupiiota); RT 4.10 min. 0.05% Aq TFA: ACN; 0.80 mL/min); TLC: 5% MeOH/ CH2C12 (R 0.7).
  • 5
  • 2-chloro-4-((2-chloroethyl)amino)pyrimidin-5-ol [ No CAS ]
  • [ 1303587-99-6 ]
YieldReaction ConditionsOperation in experiment
67% With potassium carbonate; In N,N-dimethyl-formamide; at 100℃; for 16h;Inert atmosphere; To a stirred solution of 2-chloro-4-((2-chloroethyl) amino) pyrimidin-5-ol (4 g, 19.23 mmol) in DMF (70 mL) under argon atmosphere was added potassium carbonate (7.96 g, 57.69 mmol) at RT. The reaction mixture was stirred at 100 C for 16 h. After consumption of the starting material (monitored by TLC), the reaction was diluted with water (100 mL) and extracted with EtOAc (2 x 100 mL). The combined organic extracts were dried over sodium sulfate, filtered and concentrated in vacuo. The crude material was purified by column chromatography using 40% EtOAc/hexanes to afford 2-chloro-7, 8-dihydro-6H- pyrimido [5, 4-b] [1, 4] oxazine (2.1 g, 67%) as a brown solid. ?H-NMR (DMSO-d6, 400 MHz): oe 8.29 (s, 1H), 7.65 (s, 1H), 4.13-4.10 (m, 2H), 3.46-3.43 (m, 2H); LCMS: 172 (M+1); (column; Eclipse XDB C-18 (150 x 4.6 mm, 5 jim); RT 5.61 mm. 0.05% aq TFA:ACN; 1.0 mL/min); TLC: 60% EtOAc/hexanes (R 0.5).
  • 6
  • [ 1303587-99-6 ]
  • 8-benzyl-N-(1-(6-methylpyrimidin-4-yl)piperidin-4-yl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-2-amine [ No CAS ]
  • 7
  • [ 1303587-99-6 ]
  • 8-benzyl-N-(1-(2-(trifluoromethyl)pyridin-4-yl)piperidin-4-yl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-2-amine [ No CAS ]
  • 8
  • [ 1303587-99-6 ]
  • 8-benzyl-N-(1-(2-methoxypyridin-4-yl)piperidin-4-yl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-2-amine [ No CAS ]
  • 9
  • [ 1303587-99-6 ]
  • N-(1-(6-methylpyrimidin-4-yl)piperidin-4-yl)-8-(2,2,2-trifluoroethyl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-2-amine [ No CAS ]
  • 10
  • [ 1303587-99-6 ]
  • 8-(2,2,2-trifluoroethyl)-N-(1-(2-(trifluoromethyl)pyridin-4-yl)piperidin-4-yl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-2-amine [ No CAS ]
  • 11
  • [ 1303587-99-6 ]
  • N-(1-(2-methoxypyridin-4-yl)piperidin-4-yl)-8-(2,2,2-trifluoroethyl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-2-amine [ No CAS ]
  • 12
  • [ 353-83-3 ]
  • [ 1303587-99-6 ]
  • 2-chloro-8-(2,2,2-trifluoroethyl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazine [ No CAS ]
YieldReaction ConditionsOperation in experiment
32% With caesium carbonate; In N,N-dimethyl-formamide; at 20 - 25℃; for 32h;Inert atmosphere; To a stirred solution of 2-chloro-7, 8-dihydro-6H-pyrimido [5, 4-b] [1, 4] oxazine (500 mg, 2.92 mmol) in DMF (5 mL) under argon atmosphere were added cesium carbonate (1.9 g, 5.84 mmol) and 1, 1, 1-trifluoro-2-iodoethane (611 mg, 2.92 mmol) at RT. The reaction mixture was stirred for 32 h. After consumption of the starting material (monitored by TLC), the reaction was diluted with water (20 mL) and extracted with EtOAc (2 x 20 mL). The combined organic extracts were dried over sodium sulfate, filtered and concentrated in vacuo. The crude material was purified by column chromatography using 20% EtOAc:hexanes to afford 2-chloro-8-(2, 2, 2-trifluoroethyl)-7, 8-dihydro-6H-pyrimido [5, 4- b] [1, 4] oxazine (235 mg, 32%) as an off-white solid. ?H-NMR (CDC13, 500 MHz): oe 7.79 (s, 1H), 4.30-4.28 (m, 2H), 4.27-4.23 (m, 2H), 3.70-3.68 (m, 2H); LCMS: 254.4 (M+1); (column; X-Select CSH C-18 (50 x 3.0 mm, 3.5 jim); RT 3.76 mm. 0.05% Aq TFA: ACN; 0.80 mL/min); TLC: 60% EtOAc/hexanes (R1: 0.6).
32% With caesium carbonate; In N,N-dimethyl-formamide; at 20℃; for 32h;Inert atmosphere; Synthesis of2-chloro-8-(2, 2, 2-trifluoroethyl)-7, 8-dihydro-6H-pyrimido [5, 4-b] [I, 4] oxazine [0414] To a stirred solution of 2-chloro-7, 8-dihydro-6H-pyrimido [5, 4-b] [1, 4] oxazine (500 mg, 2.92 mmol) in DMF (5 mL) under argon atmosphere were added cesium carbonate (1.9 g, 5.84 mmol) and 1, 1, l-trifluoro-2-iodoethane (611 mg, 2.92 mmol) at RT and the mixture was stirred for 32 h. After consumption of the starting materials (monitored by TLC), the reaction was diluted with water (20 mL) and extracted with EtOAc (2 x 20 mL). The combined organic extracts were dried over sodium sulfate, filtered and concentrated in vacuo. The crude material was purified by silica gel column chromatography using 20% EtOAc:hexanes to afford 2-chloro-8-(2, 2, 2-trifluoroethyl)-7, 8-dihydro-6H-pyrimido [5, 4- b] [1, 4] oxazine (235 mg, 32%) as an off-white solid. 1H-NMR (CDC13, 500 MHz): delta 7.79 (s, 1H), 4.30-4.28 (m, 2H), 4.27-4.23 (m, 2H), 3.70-3.68 (m, 2H); LC-MS: 254.4 (M+1); (column; X-Select CSH C-18 (50 3.0 mm, 3.5 mupiiota); RT 3.76 min. 0.05% Aq TFA: ACN; 0.80 mL/min); TLC: 60% EtOAc:hexanes (R/. 0.6).
  • 13
  • 2-chloro-5-(2-chloroethoxy)pyrimidin-4-amine [ No CAS ]
  • [ 1303587-99-6 ]
YieldReaction ConditionsOperation in experiment
67% With potassium carbonate; In N,N-dimethyl-formamide; at 100℃; for 16h;Inert atmosphere; Synthesis of 2-chloro-7 , 8-dihydro-6H-pyrimido [5, 4-b] [I, 4] oxazine [0348] To a stirred solution of 2-chloro-5-(2-chloroethoxy)pyrimidin-4-amine (4 g, 19.23 mmol) in DMF (70 mL) under argon atmosphere was added potassium carbonate (7.96 g, 57.69 mmol) at RT. The reaction mixture was heated to 100 C and stirred for 16 h. After completion of the reaction (monitored by TLC), the reaction was diluted with cold water (100 mL) and extracted with EtOAc (2 x 100 mL). The combined organic extracts were dried over sodium sulfate, filtered and concentrated in vacuo. The crude material was purified by silica gel column chromatography using 40% EtOAc:hexanes to afford 2-chloro-7, 8-dihydro-6H- pyrimido [5, 4-b] [1, 4] oxazine (2.1 g, 67%) as a brown solid. 1H-NMR (DMSO-< 5, 400 MHz): delta 8.29 (s, 1H), 7.65 (s, 1H), 4.13-4.10 (m, 2H), 3.46-3.43 (m, 2H); TLC: 60% EtOAc:hexanes (R/. 0.5).
  • 14
  • [ 1303587-99-6 ]
  • C24H21F3N6O2 [ No CAS ]
  • 15
  • [ 1303587-99-6 ]
  • 8-(2,4-difluorophenyl)-N-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-2-amine [ No CAS ]
  • 16
  • [ 1303587-99-6 ]
  • 8-(4-fluorophenyl)-N-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-2-amine [ No CAS ]
  • 17
  • [ 1303587-99-6 ]
  • 8-(3,5-difluorophenyl)-N-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-2-amine [ No CAS ]
  • 18
  • [ 1303587-99-6 ]
  • C26H22F3N5O2 [ No CAS ]
  • 19
  • [ 1303587-99-6 ]
  • 8-(2,4-difluorophenyl)-N-(3-methoxy-4-(2-methylpyridin-4-yl)phenyl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-2-amine [ No CAS ]
  • 20
  • [ 1303587-99-6 ]
  • 8-benzyl-N-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-2-amine [ No CAS ]
  • 21
  • [ 1303587-99-6 ]
  • 8-(4-fluorophenyl)-N-(3-methoxy-4-(2-methylpyridin-4-yl)phenyl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-2-amine [ No CAS ]
  • 22
  • [ 1303587-99-6 ]
  • N-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)-8-((tetrahydro-2H-pyran-4-yl)methyl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-2-amine [ No CAS ]
  • 23
  • [ 1303587-99-6 ]
  • 8-benzyl-N-(3-methoxy-4-(2-methylpyridin-4-yl)phenyl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-2-amine [ No CAS ]
  • 24
  • [ 1303587-99-6 ]
  • N-(3-methoxy-4-(2-methylpyridin-4-yl)phenyl)-8-(tetrahydro-2H-pyran-4-yl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-2-amine [ No CAS ]
  • 25
  • [ 1303587-99-6 ]
  • N-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)-8-(3,4,5-trifluorophenyl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-2-amine [ No CAS ]
  • 26
  • [ 1303587-99-6 ]
  • 8-(2-chlorophenyl)-N-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-2-amine [ No CAS ]
  • 27
  • [ 1303587-99-6 ]
  • 8-(2-chlorophenyl)-N-(3-methoxy-4-(2-methylpyridin-4-yl)phenyl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-2-amine [ No CAS ]
  • 28
  • [ 1303587-99-6 ]
  • 8-(3,5-difluorophenyl)-N-(3-methoxy-4-(2-methylpyridin-4-yl)phenyl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-2-amine [ No CAS ]
  • 29
  • [ 1303587-99-6 ]
  • N-(3-methoxy-4-(2-methylpyridin-4-yl)phenyl)-8-(3,4,5-trifluorophenyl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-2-amine [ No CAS ]
  • 30
  • [ 1303587-99-6 ]
  • N-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)-8-(2,2,2-trifluoroethyl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-2-amine [ No CAS ]
  • 31
  • [ 1303587-99-6 ]
  • 8-benzyl-N-(3-fluoro-4-(2-methylpyridin-4-yl)phenyl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-2-amine [ No CAS ]
  • 32
  • [ 1303587-99-6 ]
  • 8-benzyl-N-(3-fluoro-4-(4-methyl-1H-imidazol-1-yl)phenyl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-2-amine [ No CAS ]
  • 33
  • [ 1303587-99-6 ]
  • N-(3-fluoro-4-(2-methylpyridin-4-yl)phenyl)-8-(2,2,2-trifluoroethyl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-2-amine [ No CAS ]
  • 34
  • [ 1303587-99-6 ]
  • N-(3-fluoro-4-(4-methyl-1H-imidazol-1-yl)phenyl)-8-(2,2,2-trifluoroethyl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-2-amine [ No CAS ]
  • 35
  • [ 1303587-99-6 ]
  • N-(3-methoxy-4-(2-methylpyridin-4-yl)phenyl)-8-(2,2,2-trifluoroethyl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-2-amine [ No CAS ]
  • 36
  • [ 1303587-99-6 ]
  • N-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)-8-methyl-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-2-amine [ No CAS ]
  • 37
  • [ 1303587-99-6 ]
  • (2-((3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)amino)-6,7-dihydro-8H-pyrimido[5,4-b][1,4]oxazin-8-yl)(phenyl)methanone [ No CAS ]
  • 38
  • [ 1303587-99-6 ]
  • 8-(2-fluorophenyl)-N-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-2-amine [ No CAS ]
  • 39
  • [ 1303587-99-6 ]
  • 5-fluoro-2-(2-((3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)amino)-6,7-dihydro-8H-pyrimido[5,4-b][1,4]oxazin-8-yl)benzonitrile [ No CAS ]
  • 40
  • [ 1303587-99-6 ]
  • 8-(4-fluorobenzyl)-N-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-2-amine [ No CAS ]
  • 41
  • [ 1303587-99-6 ]
  • 8-(4-chlorobenzyl)-N-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-2-amine [ No CAS ]
  • 42
  • [ 1303587-99-6 ]
  • N-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)-8-(1-phenylethyl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-2-amine [ No CAS ]
  • 43
  • [ 1303587-99-6 ]
  • (+)-N-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)-8-(1-phenylethyl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-2-amine [ No CAS ]
  • (-)-N-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)-8-(1-phenylethyl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-2-amine [ No CAS ]
  • 44
  • [ 1303587-99-6 ]
  • 8-(3-chlorobenzyl)-N-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-2-amine [ No CAS ]
  • 45
  • [ 1303587-99-6 ]
  • N-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)-8-(4-(trifluoromethoxy)benzyl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-2-amine [ No CAS ]
  • 46
  • [ 1303587-99-6 ]
  • N-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)-8-phenethyl-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-2-amine [ No CAS ]
  • 47
  • [ 1303587-99-6 ]
  • N-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)-8-(2-(trifluoromethyl)benzyl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-2-amine [ No CAS ]
  • 48
  • [ 1303587-99-6 ]
  • N-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)-8-(4-(trifluoromethyl)benzyl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-2-amine [ No CAS ]
  • 49
  • [ 1303587-99-6 ]
  • N-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)-8-(3-(trifluoromethyl)benzyl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-2-amine [ No CAS ]
  • 50
  • [ 1303587-99-6 ]
  • 8-(2-chlorobenzyl)-N-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-2-amine [ No CAS ]
  • 51
  • [ 1303587-99-6 ]
  • 8-(2-cyclopropoxy-4-fluorophenyl)-N-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-2-amine [ No CAS ]
  • 52
  • [ 1161361-88-1 ]
  • [ 1303587-99-6 ]
  • N-(3-methoxy-4-(2-methylpyridin-4-yl)phenyl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-2-amine [ No CAS ]
YieldReaction ConditionsOperation in experiment
47% With hydrogenchloride; In water; isopropyl alcohol; at 120℃; for 48h;Inert atmosphere; Sealed tube; Synthesis ofN-(3-methoxy-4-(2-methylpyridin-4-yl) phenyl)-, 8-dihydro-6H-pyrimido [5, 4- b] [I, 4] oxazin-2-amine [0350] To a stirred solution of 2-chloro-7, 8-dihydro-6H-pyrimido [5, 4-b] [1, 4] oxazine (1 g, 5.81 mmol) in isopropyl alcohol (20 mL) under argon atmosphere were added 3- methoxy-4-(2-methylpyridin-4-yl) aniline (1.2 g, 5.81 mmol) and concentrated hydrochloric acid (12M, 0.5 mL) at RT. The reaction mixture was stirred at 120 C for 48 h in a sealed tube. After completion of the reaction (monitored by TLC), the volatile components were removed in vacuo. The resultant residue was basified with a saturated sodium bicarbonate solution (50 mL) and extracted with a 10% MeOH:CH2Cl2 solution (2 x 50 mL). The combined organic extracts were dried over sodium sulfate, filtered and concentrated in vacuo. The crude material was purified by silica gel column chromatography using 6% MeOH:CH2Cl2 to afford N-(3-methoxy-4-(2-methylpyridin-4-yl) phenyl)-7, 8-dihydro-6H- pyrimido [5, 4-b] [1, 4] oxazin-2-amine (950 mg, 47%) as a pale yellow solid. 1H-NMR (DMSO-d6, 500 MHz): delta 8.96 (s, IH), 8.36-8.35 (m, IH), 7.73 (s, IH), 7.51 (s, IH), 7.37 (d, 2H), 7.33 (s, IH), 7.29-7.28 (m, IH), 7.21 (d, IH), 4.07-4.05 (m, 2H), 3.78 (s, 3H), 3.45-3.43 (m, 2H), 2.47 (s, 3H); LC-MS: 350.2 (M+1); (column; X-Bridge C-18 (50 3.0 mm, 3.5 mupiiota); RT 2.47 min. 0.05% aq TFA: ACN; 0.80 mL/min); UPLC (column; Acquity UPLC BEH C-18 2.1 X 50 mm, 1.7 mupiiota); RT 1.20 min. ACN: 0.025% TFA (Aq); 0.50 mL/min; TLC: 10% MeOH:CH2Cl2 (R/. 0.6).
  • 53
  • [ 1303587-99-6 ]
  • [ 98-88-4 ]
  • (2-chloro-6,7-dihydro-8H-pyrimido[5,4-b][1,4]oxazin-8-yl)(phenyl)methanone [ No CAS ]
YieldReaction ConditionsOperation in experiment
66% With sodium hydride; In N,N-dimethyl-formamide; mineral oil; at 0℃; for 0.166667h;Inert atmosphere; Synthesis of (2-chloro-6, 7-dihydro-8H-pyrimido [5, 4-b] [I, 4] omicronchialphazetaeta-8-yl) (phenyl) methanone [0426] To a stirred solution of 2-chloro-7, 8-dihydro-6H-pyrimido [5, 4-b] [1, 4] oxazine (150 mg, 0.87 mmol) in DMF (1.5 mL) under argon atmosphere were added sodium hydride (70 mg, 1.74 mmol) and benzoyl chloride (184 mg, 1.30 mmol) at 0C. The reaction mixture was stirred for 10 min at 0 C. After consumption of the starting materials (monitored by TLC), the reaction was quenched with water (50 mL) and extracted with EtOAc (2 x 50 mL). The combined organic extracts were washed with a saturated sodium bicarbonate solution (20 mL), dried over sodium sulfate, filtered and concentrated in vacuo. The crude material was purified by column chromatography using 35% EtOAc:hexanes to afford (2-chloro-6, 7- dihydro-8H-pyrimido [5, 4-b] [1, 4] oxazin-8-yl) (phenyl) methanone (160 mg, 66%>) as an off-white solid. 1H-NMR (CDC13, 500 MHz): delta 8.10 (s, 1H), 7.53-7.50 (m, 3H), 7.40-7.38 (m, 2H), 4.50-4.47 (m, 2H), 4.10-4.08 (m, 2H); LCMS: 276.3 (M+1); (column; X-Select CSH C-18 (50 3.0 mm, 3.5 mupiiota); RT 3.89 min. 0.05% Aq TFA: ACN; 0.80 mL/min); TLC: 50% EtOAc:hexanes (R 0.5).
  • 54
  • [ 1303587-99-6 ]
  • [ 459-46-1 ]
  • 2-chloro-8-(4-fluorobenzyl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazine [ No CAS ]
YieldReaction ConditionsOperation in experiment
92% With sodium hydride; In N,N-dimethyl-formamide; mineral oil; at 0℃; for 1h;Inert atmosphere; Synthesis of 2-chloro-8-(4-fluorobenzyl)-7 , 8-dihydro-6H-pyrimido [5, 4-b] [I, 4] oxazine [0440] To a stirred solution of 2-chloro-7, 8-dihydro-6H-pyrimido [5, 4-b] [1, 4] oxazine (100 mg, 0.58 mmol) in DMF (1 mL) under argon atmosphere was added sodium hydride (27 mg, 1.16 mmol) at 0 C. After stirring for 10 mins, l-(bromomethyl)-4-fluorobenzene (132 mg, 0.70 mmol) was added at 0 C and stirred for 1 h. After consumption of the starting materials (monitored by TLC), the reaction was quenched with ice water (20 mL) and extracted with EtOAc (2 x 20 mL). The combined organic extracts were dried over sodium sulfate, filtered and concentrated in vacuo to afford 2-chloro-8-(4-fluorobenzyl)-7, 8-dihydro- 6H-pyrimido [5, 4-b] [1, 4] oxazine (150 mg, 92%) as an off-white solid. 1H-NMR (DMSO- d6, 400 MHz): delta 7.70 (s, 1H), 7.36 (t, 2H), 7.18 (t, 2H), 4.75 (s, 2H), 4.19-4.16 (m, 2H), 3.51- 3.48 (m, 2H); LCMS: 279.9 (M+1); (column; X-Select CSH C-18 (50 3.0 mm, 3.5 mupiiota); RT 3.59 min 0.05% Aq TFA: ACN; 0.80 mL/min); TLC: 60% EtOAc/hexane (R 0.5).
  • 55
  • [ 1303587-99-6 ]
  • [ 622-95-7 ]
  • 2-chloro-8-(4-chlorobenzyl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazine [ No CAS ]
YieldReaction ConditionsOperation in experiment
73% With sodium hydride; In N,N-dimethyl-formamide; mineral oil; at 0℃; for 1h;Inert atmosphere; Synthesis of 2-chloro-8-(4-chlorobenzyl)-7 , 8-dihydro-6H-pyrimido [5, 4-b] [I, 4] oxazine [0450] To a stirred solution of 2-chloro-7, 8-dihydro-6H-pyrimido [5, 4-b] [1, 4] oxazine (150 mg, 0.87 mmol) in DMF (3 mL) under argon atmosphere were added sodium hydride (40 mg, 1.75 mmol) and l-(bromomethyl)-4-chlorobenzene (215 mg, 1.05 mmol) at 0 C. The reaction mixture was stirred for 1 h at 0 C. After consumption of the starting materials (monitored by TLC), the reaction was diluted with water (50 mL) and extracted with EtOAc (2 x 50 mL). The combined organic extracts were dried over sodium sulfate, filtered and concentrated in vacuo. The crude material was washed with n-pentane (2 x 5 mL) to afford 2- chloro-8-(4-chlorobenzyl)-7, 8-dihydro-6H-pyrimido [5, 4-b] [1, 4] oxazine (190 mg, 73%) as an off-white solid. 1H-NMR (DMSO-<, 500 MHz): delta 7.73 (s, 1H), 7.42 (d, 2H), 7.33 (d, 2H), 4.78 (s, 2H), 4.20-4.18 (m, 2H), 3.52-3.49 (m, 2H); LCMS: 295.8 (M+); (column; X- Select CSH C-18 (50 3.0 mm, 3.5 mupiiota); RT 3.81 min. 0.05% Aq TFA: ACN; 0.80 mL/min); UPLC (purity): 91.4%; (column; Acquity UPLC BEH C-18 2.1 X 50 mm, 1.7 mupiiota); RT 2.52 min. ACN: 0.025% TFA (Aq); 0.50 mL/min; TLC: 30% EtOAc:hexanes (R 0.6).
 

Historical Records

Technical Information

Categories